Report License

$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off

Order Review

Myelodysplastic Syndrome (MDS) Drugs Market - By Drug Type (Hypomethylating, Immune Therapy, Anti-anaemics), Route of Administration (Oral, Parenteral), Medication (Branded, Generic), Cancer Type, Age Group, End-user – Global Forecast 2024 – 2032

Report ID: GMI10852
Selected License: $8,350
Discount: $2,505
Order Total: $5,845

Need assistance?

Call us or write to us:

What You Get?

Billing Information

Payment Method


creditCardImage
Top